GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of unpopular opinion: telehealth is massively overrated — 19 comments in the full submission. View in context.
203
c/compounding·submitted 5 months ago by u/camila_sandvik

unpopular opinion: telehealth is massively overrated

Regulatorybranch of 5 comments

shortage list. That is the whole post, but I will justify it. Everything else people worry about in c/coldchain is downstream of it. Titration speed, early fullness, the endless dose arguments — most of it resolves if you sort shortage list out first, and almost nobody does. I say this having got it wrong for 7…

Read the full submission and all 19 comments →

This branch

5 comments, started 5 months ago
u/quiet_moderatorMOD9 points·5 months ago

Removed a chain here. The rule is one line long and it is not negotiable.

replysharereportpermalink
u/formulary_fighterappeals4 points·5 months ago

Slight fix: the number was 96.8, not 97.2. Decimal point, but a fairly consequential one.

replysharereportpermalink
u/camila_sandvikOP2 points·5 months ago

The 503A pharmacy I used lost their shortage list eligibility. Same day, compounding became illegal. Rules are real.

replysharereportpermalink
u/anya_antonsen2 points·5 months ago

the shortage list is temporary, it ends and compounding becomes illegal again

replysharereportpermalink
u/camila_sandvikOP1 point·5 months ago

API transparency is the question that separates good compounders from sketchy ones

replysharereportpermalink

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/compounding
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/formulary_fighteru/usp_appendixu/quiet_moderatoru/prior_auth_pain
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →